EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Genetic Variants at the CDKN1B and CCND2 Loci Encoding p27Kip1 and Cyclin D2 Cell Cycle Regulators with Susceptibility and Clinical Course of Chronic Lymphocytic Leukemia

Lidia Ciszak iD, Agata Kosmaczewska iD, Edyta Pawlak iD, Irena Frydecka, Aleksandra Szteblich, Dariusz Wołowiec

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lidia Ciszak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland. Hauptthemen laut MEDLINE: Cyclin D2, Cyclin-Dependent Kinase Inhibitor p27, Leukemia, Lymphocytic, Chronic, B-Cell, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beyond the essential role of p27Kip1 and cyclin D2 in cell cycle progression, they are also shown to confer an anti-apoptotic function in peripheral blood (PB) lymphocytes. Although the aberrant longevity and expression of p27Kip1 and cyclin D2 in leukemic cells is well documented, the exact mechanisms responsible for this phenomenon have yet to be elucidated. This study was undertaken to determine the associations between polymorphisms in the CDKN1B and CCND2 genes (encoding p27Kip1 and cyclin D2, respectively) and susceptibility to chronic lymphocytic leukemia (CLL), as well as their influence on the expression of both cell cycle regulators in PB leukemic B cells and non-malignant T cells from untreated CLL patients divided according to the genetic determinants studied. Three CDKN1B single-nucleotide polymorphisms (SNPs), rs36228499, rs34330, and rs2066827, and three CCND2 SNPs, rs3217933, rs3217901, and rs3217810, were genotyped using a real-time PCR system. The expression of p27Kip1 and cyclin D2 proteins in both leukemic B cells and non-malignant T cells was determined using flow cytometry. We found that the rs36228499A and rs34330T alleles in CDKN1B and the rs3217810T allele in the CCND2 gene were more frequent in patients and were associated with increased CLL risk. Moreover, we observed that patients possessing the CCND2rs3217901G allele had lower susceptibility to CLL (most pronounced in the AG genotype). We also noticed that the presence of the CDKN1Brs36228499CC, CDKN1Brs34330CC, CDKN1Brs2066827TT, and CCND2rs3217901AG genotypes shortened the time to CLL progression. Statistically significant functional relationships were limited to T cells and assigned to CDKN1B polymorphic variants; carriers of the polymorphisms rs34330CC and rs36228499CC (determining the aggressive course of CLL) expressed a decrease in p27Kip1 and cyclin D2 levels, respectively. We indicate for the first time that genetic variants at the CDKN1B and CCND2 loci may be considered as a potentially low-penetrating risk factor for CLL and determining the clinical outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin D2Cyclin-Dependent Kinase Inhibitor p27Leukemia, Lymphocytic, Chronic, B-CellPolymorphism, Single NucleotideGenetic Predisposition to DiseaseHumansMaleFemaleMiddle AgedAgedAdultB-LymphocytesGenotype

Stichwörter der Autor:innen

CCND2 gene polymorphismCDKN1B gene polymorphismchronic lymphocytic leukemia (CLL)cyclin D2p27Kip1 protein

Substanzen

Cyclin D2Cyclin-Dependent Kinase Inhibitor p27CCND2 protein, humanCDKN1B protein, human

Autor:innen und Institutionen

  • Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
  • Clinical Department of Hematology, Cell Therapies and Internal Diseases, Wroclaw Medical University, 50-367 Wroclaw, Poland.

ORCID-Profile: Lidia Ciszak, Agata Kosmaczewska, Edyta Pawlak

Förderung

  • Wroclaw Medical University

Zitieren

APA

Ciszak, L., Kosmaczewska, A., Pawlak, E., Frydecka, I., Szteblich, A., & Wołowiec, D. (2024). Association of Genetic Variants at the CDKN1B and CCND2 Loci Encoding p27Kip1 and Cyclin D2 Cell Cycle Regulators with Susceptibility and Clinical Course of Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111705

Vancouver

Ciszak L, Kosmaczewska A, Pawlak E, Frydecka I, Szteblich A, Wołowiec D. Association of Genetic Variants at the CDKN1B and CCND2 Loci Encoding p27Kip1 and Cyclin D2 Cell Cycle Regulators with Susceptibility and Clinical Course of Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111705

BibTeX
@article{Ciszak2024,
  author = {Ciszak, Lidia and Kosmaczewska, Agata and Pawlak, Edyta and Frydecka, Irena and Szteblich, Aleksandra and Wołowiec, Dariusz},
  title = {Association of Genetic Variants at the CDKN1B and CCND2 Loci Encoding p27Kip1 and Cyclin D2 Cell Cycle Regulators with Susceptibility and Clinical Course of Chronic Lymphocytic Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111705}
}
Kostenlos starten →